News
We have a bumper crop of promotions this year as part of the 2022 Annual Review process for academic staff.
News
We have a bumper crop of promotions this year as part of the 2022 Annual Review process for academic staff.
News
Dr Michele Tinti recently participated in a biomedicine crowdsourced challenge instigated by DREAM Challenges. Michele was placed 10th out of almost 300 registered participants and 26 finalist teams.
News
UK Biobank recently announced the appointment of Professor Sir Michael Ferguson to its Board.
News
Clues to the mechanism of yeast infections, which present risks to both humans and crops, have been identified.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
Michele Tinti, a postdoctoral researcher in Mike Ferguson’s lab, has competed on the international stage to search for a stable mRNA sequence in order to create a stable COVID-19 vaccine.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
News
Joana Faria has been awarded a SULSA Early Career Research Prize for Development and Regulation.
News
The finalists for Converge 2020, Scotland’s leading academic company creation programme, have been announced with representation from the School included on the list with Dr Robyn Hickerson, Co-founder and Chief Scientific Officer of Ten Bio.
News
The mechanism of a protein which transports ammonium across cell membranes has been discovered in research led at the University of Strathclyde, in collaboration with the University of Dundee and the Université Libre de Bruxelles.
News
Researchers in the School have discovered a new neurodevelopmental disease caused by genetic mutations and helped explain why patients with these mutations suffer this condition.
News
new theory on collective cell migration has been published in Nature Communications this week.
News
An interdisciplinary study investigating cell membrane dynamics has been published in Science Advances.
News
Sumitomo Dainippon Pharma and Exscientia announce that a phase I clinical study of DSP-1181, that was created using Artificial Intelligence (AI), has been initiated in Japan for the treatment of obsessive-compulsive disorder as an initial indication.